Publications by authors named "Andre Saad Cleto"
Aims: Dyslipidemia is a risk factor for cardiovascular diseases. Some patients are resistant to conventional treatment. In these patients, there is the possibility of using PCSK9 inhibitors.
View Article and Find Full Text PDFArticle Synopsis
- Semaglutide, a GLP-1 receptor agonist, helps reduce blood sugar levels and weight in overweight or obese individuals, and the study aimed to assess its impact on cardiovascular outcomes and side effects.
- After reviewing a total of 38 studies, results showed that semaglutide significantly decreased risks of hospitalization for heart failure, cardiovascular-related deaths, and other serious heart conditions.
- The conclusion indicates that while semaglutide effectively reduces various cardiovascular risks, it also comes with a higher relative risk of experiencing adverse effects compared to some other treatments.
This review aimed to assess which surgical technique has better outcomes to correct one of the most common congenital anomalies of the upper limb: syndactyly. The following databases were used in the search: PubMed, Embase, Cochrane (CENTRAL), LILACS, SciELO, Scopus and Web of Science, on October 27, 2022. Studies that described a surgical technique for correcting syndactyly and evaluated surgical complications were included.
View Article and Find Full Text PDF